Health Care: Drugs

Impax Laboratories Inc (IPXL: NASDAQ)

$40.7 n/a | n/a%
02/26/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 40.70
52 Week High 41.39
52 Week Low 22.12
Avg. Daily Vol. (Mil) 0.67
Beta (3 year) 1.61
Share Related Items
Mkt Cap (Mil) 2,899.81
Shares Out (Mil) 71.25
Float (Mil) 59.08
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.50
Current Ratio 4.40
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings 50.10
Price/Sales 4.87
Price/Book 3.26
Price/Cash Flow 37.70
Per Share Data
Earnings 0.81
Sales 8.37
Book Value 12.47
Cash Flow 1.08
Business Summary
Impax Laboratories, Inc., is a technology-based, specialty pharmaceutical company focused on the development and commercialization of bioequivalent and brand-name pharmaceuticals, utilizing its controlled-release and other in-house development.
General Information
30831 Huntwood Avenue
Hayward, CA 94544
Industry : Drugs
Sector: Health Care
Employees: 973
CEO: G. Frederick Wilkinson
Short Interest
Current Month (Mil) 9.32
Previous Month (Mil) 9.61
Short Interest Ratio (Days) 17.00
Management Effectiveness
Return on Equity 5.40
Return on Assets 4.40
Return on Investments 5.40
Gross Margin 55.80
EBIT Margin 13.00
Profit Margin 9.60

Portfolios with IPXL

Latest IPXL Headlines from TheStreet

More Financial News for IPXL

Press Releases for IPXL

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter